Skip to main content
Signal8

Gladstein Lana

SEC insider (Form 3/4/5 filer). CIK 0002127496. General Counsel at Seaport Therapeutics, Inc. (SPTX). 2 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in BOSTON, MA.

Companies Gladstein Lana has filed insider reports for

  • Seaport Therapeutics, Inc. (SPTX): Officer, General Counsel
Gladstein Lana profile photo

Gladstein Lana

CIK: 0002127496

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Seaport Therapeutics, Inc. logo
SPTX

Seaport Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Seaport Therapeutics, Inc. logo
    SPTX

    Seaport Therapeutics, Inc.

    May 4, 2026
    Conversion
    Direct
    33.5K shares-
  • Seaport Therapeutics, Inc. logo
    SPTX

    Seaport Therapeutics, Inc.

    Apr 30, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    63.7K shares-

1-2 of 2